Basit öğe kaydını göster

dc.contributor.authorAraman, A
dc.contributor.authorHas, Recep
dc.contributor.authorCevher, E
dc.contributor.authorKilic, G
dc.contributor.authorIbrahimoglu, L
dc.contributor.authorBatukan, C
dc.contributor.authorErmis, H
dc.date.accessioned2021-03-04T08:45:40Z
dc.date.available2021-03-04T08:45:40Z
dc.date.issued2002
dc.identifier.citationHas R., Batukan C., Ermis H., Cevher E., Araman A., Kilic G., Ibrahimoglu L., "Comparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction.", Gynecologic and obstetric investigation, cilt.53, sa.1, ss.16-21, 2002
dc.identifier.issn0378-7346
dc.identifier.otherav_64e29880-b598-44be-9fe6-51efa3821630
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/70177
dc.identifier.urihttps://doi.org/10.1159/000049405
dc.description.abstractOur purpose was to compare the efficacy of 25 lug and 50 mug intravaginally administered misoprostol tablets for cervical ripening and labor induction. Either 25-mug (n: 58) or 50-mug (n: 56) misoprostol tablets were randomly administered intravaginally to 114 subjects with an unripe cervix for labor induction. The physician was blinded to the medication. Intravaginal misoprostol was given every 4 h until the onset of labor. The mean Bishop score before misoprostol administration was 2.1 +/- 1.6 in the 25-mug group and 2.0 +/- 1.4 in the 50-mug group (p > 0.05). With the 25-mug dose the time until delivery was significantly longer (991.2 +/- 514.4 min vs. 703.12 +/- 432.6 min in the 50-mug group). The use of oxytocin augmentation was significantly higher in the 25-mug group (63.8%) than the 50-mug group (32.1%; p 0.05). Overall, in the 25mug group more women achieved vaginal delivery (79.3 vs. 60.7%; p 0.05). One patient in the 25-mug group suffered a ruptured uterus. Intravaginal administration of 25 lug of misoprostol is a clinically effective labor induction regimen and has the least adverse effects and complications. Copyright (C) 2002 S. Karger AG, Basel.
dc.language.isoeng
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.titleComparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction.
dc.typeMakale
dc.relation.journalGynecologic and obstetric investigation
dc.contributor.department, ,
dc.identifier.volume53
dc.identifier.issue1
dc.identifier.startpage16
dc.identifier.endpage21
dc.contributor.firstauthorID163903


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster